Source: Reuters AMSTERDAM, Nov 14 (Reuters) – Philips (PHG.AS), the medical equipment maker that is recalling ventilators due to use of parts containing a potentially hazardous foam,...
Source: Reuters Nov 12 (Reuters) – Healthcare conglomerate Johnson & Johnson’s (JNJ.N) will soon spin-off its consumer health division, giving up a part of the company that has...
Source: Reuters Nov 10 (Reuters) – Roche Holding AG (ROG.S), still months away from seeking regulatory approval of its experimental Alzheimer’s drug, is already taking aim at...
Source: Reuters CARACAS, Nov 8 (Reuters) – Venezuela has begun vaccinating children aged 2 to 11 against COVID-19 with the Cuban Soberana 2 vaccine, Vice President Delcy...
Source: Reuters FRANKFURT, Nov 7 (Reuters) – Alzheimer’s drug developer AC Immune (ACIU.O) expects the number of families to be affected by the degenerative disease could nearly triple...
Source: Reuters Nov 5 (Reuters) – GlaxoSmithKline (GSK.L) said its anaemia pill for patients with kidney disease was shown to have about the same side effect risk as...
Source: Reuters WASHINGTON, Nov 1 (Reuters) – Two months after letting a near-total ban on abortion in Texas take effect, conservative U.S. Supreme Court justices on...
Source: Reuters YOGYAKARTA, Indonesia, Nov 1 (Reuters) – Researchers in Indonesia have found a way to fight disease-bearing mosquitoes by breeding a species of the insect...
Source: Reuters Oct 29 (Reuters) – Signs of post-traumatic stress disorder (PTSD) seen in frontline healthcare workers during the COVID-19 pandemic may be linked to trauma...
Source: Reuters Oct 26 (Reuters) – Cortexyme Inc (CRTX.O) said on Tuesday its experimental oral pill failed to meet the main goals of improving cognitive and functional abilities...
